term vertebrate cell culture systems (Chow et al., 1995; Enari et al., 1995; Fearnhead et al., 1995; Los et al., Recognition of the widespread importance of apoptosis 1995; Milligan et al., 1995; Zhu et al., 1995 ; Jacobson has been one of the most significant changes in Schlegel et al., 1996; Slee et al., 1996) biomedical sciences in the past decade. The molecular including the early formation of high-molecular weight processes controlling and executing cell death through DNA fragments (Zhu et al., 1995) . However, it is not yet apoptosis are, however, still poorly understood. The known if the process can be completely prevented in this ICE (Interleukin-1β Converting Enzyme) familyway, or if it is merely delayed, with the cells dying, either recently named the caspases for cysteine aspartatethrough necrosis or apoptosis, some days later. Indeed, specific proteases-plays a central role in apoptosis analysis of the effect of the peptide inhibitor Z-VAD.fmk and may well constitute part of the conserved core on apoptosis in Rat-1 fibroblasts has suggested that caspase mechanism of the process. Potentially, these proteases activity is not required for plasma membrane blebbing, may be of great significance, both in the pathology an early event in apoptosis, in this system (McCarthy associated with failure of apoptosis and also as targets et al., 1997) . In addition, previous studies on vertebrate for therapeutic intervention where apoptosis occurs or invertebrate cells have not employed colony-forming inappropriately, e.g. in degenerative disease and AIDS.
assays, and it is therefore crucial to determine whether However, this is only likely if caspase activity is required mammalian cells protected from apoptosis by suppression before commitment to mammalian cell death. Here, of caspase activity can survive and subsequently form we have used both peptide inhibitors and crmA transcolonies. fection to inhibit these proteases in intact cells. Our
In mammalian cells, apoptosis can be induced by a experiments show that selective inhibition of some diverse range of stimuli, many of which are cell typecaspases protects human T cells (Jurkat and CEM-C7) specific (Wyllie et al., 1980; Martin and Green, 1995 ; from Fas-induced apoptosis, dramatically increasing Thompson, 1995; Hale et al., 1996) . Induction of apoptosis their survival (up to 320-fold) in a colony-forming in T lymphocytes expressing the cell surface receptor Fas assay. This suggests that dysfunction of some, but not (Apo-1/CD95) (Trauth et al., 1989; Yonehara et al., 1989 ) all, caspases could indeed play a crucial part in the is likely to be an important element in the physiological development of some cancers and autoimmune disease, regulation of T-cell populations, particularly in the later and also that these proteases could be appropriate stages of an immune response, and in T-cell-mediated molecular targets for preventing apoptosis in degenercytotoxicity (Rouvier et al., 1993 ; Nagata and Golstein, ative disease. Enari et al., 1996; Jacobson et al., 1996; Slee et al., 1996) , but their involvement in commitment to cell death Studies on a range of experimental systems have suggested has not previously been analysed. that the ICE family of cysteine proteases, recently renamed the caspases (Alnemri et al., 1996) , play a central role in active cell death which has been conserved over a long
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period of evolution (reviewed by Thompson, 1995; also Martin and Green, 1995; Yuan, 1995; Hale et al., 1996;  Peptide inhibitors of caspases inhibit Fas-induced markers of apoptosis in Jurkat T cells Whyte, 1996) . In Caenorhabditis elegans, loss of function of ced-3, which encodes a nematode caspase, prevents Consistent with previous reports (Enari et al., 1995; Schlegel et al., 1995; Slee et al., 1996) , treatment with developmentally programmed cell death (Ellis and Horvitz, 1986) , and in Drosophila, inhibition of caspases inhibits anti-Fas antibody induced apoptosis in the human T-cell line Jurkat, resulting in chromosomal condensation, both developmental apoptosis (White et al., 1996) and that induced artificially by transfection of the apoptosis degradation of DNA to oligonucleosomal fragments, and loss of plasma membrane integrity (Figure 1 ). Incubation inducer reaper (Pronk et al., 1996) . with Z-VAD.fmk [benzyloxycarbonyl-Val-Ala-Asp (OMe) Z-DEVD.fmk, like Ac-DEVD-CHO (Nicholson et al., 1995) , is a selective inhibitor of the CPP32/Apopain/ fluoromethylketone], a peptide caspase inhibitor (Chow et al., 1995; Jacobson et al., 1996; Slee et al., 1996) Yama/caspase-3 sub-family and its effects are likely to include inhibition of MACH/FLICE/caspase-8 which may produced substantial inhibition both of loss of membrane integrity and of the appearance of apoptotic morphology play an important role in linking Fas-induced intracellular signals to the cysteine proteases (Boldin et al., 1996; and oligonucleosomal DNA fragments (Figure 1 ). Z-DEVD.fmk also inhibited these changes, although at Muzio et al., 1996) . Z-YVAD.cmk, a selective inhibitor of the ICE/caspase-1 sub-family also inhibited apoptosis a higher concentration than required for Z-VAD.fmk.
but was noticeably less effective than the other inhibitors ( Figure 1) . One of the earliest intracellular events of apoptosis in a range of systems is the cleavage of the nuclear enzyme poly(ADPRibose) polymerase (PARP) (Kaufmann et al., 1993; Lazebnik et al., 1994) . Treatment of Jurkat cells with anti-Fas antibodies induced PARP cleavage, resulting in conversion of the 116 kDa polypeptide to the characteristic 85 kDa cleavage product, as indicated by Western blotting (Figure 2 ). All the caspase peptide inhibitors previously used markedly inhibited PARP cleavage, as did the aspartate-based protease inhibitor Boc-D.fmk (Mashima et al., 1995) . Inhibition by Z-YVAD was incomplete and some 85 kDa cleavage product was detectable.
Jurkat cells rescued from Fas-induced apoptosis by peptide inhibitors retain proliferative and colony-forming ability In order to determine if a genuine rescue from the process of apoptosis was accomplished, we first examined the effect of Z-VAD.fmk on cellular capacity for proliferation and colony formation on induction of apoptosis. Jurkat cells treated with anti-Fas antibody in the presence of Z-VAD.fmk not only maintained high viability, but even continued to proliferate, though at a reduced rate relative to that of untreated cells (Figure 3 ). We therefore examined changes in cell survival as measured by the most stringent of criteria-the ability to form a colony from a single cell. Addition of anti-Fas antibody, as expected, produced a substantial reduction in colonies subsequently formed in soft agar. The presence of Z-VAD.fmk, however, produced a 26-fold (SE ϭ 6, from three separate experiments) increase in the number of colony-forming cells surviving this treatment (Figure 3 ), indicating that caspases are required for commitment to Fas-mediated apoptosis in Jurkat cells. Lower concentrations of the inhibitor tested produced a lower level of protection (data not shown).
Since Z-VAD.fmk is a general inhibitor of caspases, we examined the effect of more selective inhibitors, i.e. Z-DEVD.fmk, which preferentially inhibits the CPP32/ CrmA transient transfection also produces increased colony formation after anti-Fas caspase-3 sub-family (Nicholson et al., 1995) , and Z-YVAD.cmk, which preferentially inhibits ICE/caspase-1 treatment Transfection with vectors expressing the gene for CrmA sub-family proteases. Z-DEVD.fmk allowed cell proliferation in the presence of anti-Fas antibody to a noticeably (Ray et al., 1992) , a cowpox virus serpin, or microinjection of this protein, has provided a complementary greater extent than did Z-VAD.fmk. Consistent with this, Z-DEVD.fmk produced a dramatic increase [321-fold approach to caspase inhibition, which circumvents potential difficulties associated with differences in cell perme-(SE ϭ 47 from three separate experiments)] in the colonyforming cells surviving treatment with anti-Fas antibody ability to the peptide inhibitors (Ray et al., 1992; Gagliardini et al., 1994; Los et al., 1995; Martin and (Figure 4) .
The effect produced by Z-YVAD.cmk contrasted Green, 1995; Tewari and Dixit, 1995; Yuan, 1995; Whyte, 1996; Jacobson et al., 1996) . Because of the inhibition of strongly with the other two inhibitors. Even at concentrations as high as 500 μM (higher concentrations are cell growth in Jurkat cells stably transfected with crmA, noted by ourselves and others (Enari et al., 1995) , we precluded by significant toxicity), Z-YVAD.cmk failed to allow sustained proliferation in the presence of anti-Fas used a transient expression system to analyse the effect of CrmA on the production of colonies after treatment antibodies and produced no increase in colony-forming cells surviving treatment ( Figure 5 ). No protection was with anti-Fas antibodies. This approach also eliminated any possible artefacts associated with selection of clones. seen in these assays with lower concentrations of Z-YVAD.cmk (data not shown).
Transient CrmA expression produced a significant increase in the number of colonies after Fas treatment ( Figure 6 ).
Caspase inhibitors also inhibit commitment to Fas-mediated death in CEM-C7 cells
Although the Jurkat cell line has been extensively used as an experimental system for the study of Fas-mediated apoptosis, it was important to confirm our observations independently in another cell line. Apoptosis, indicated by appearance of apoptotic morphology and breakdown ( Figure 7 ). Apoptosis was confirmed by the appearance of a strong oligonucleosomal DNA ladder on agarose the peptide inhibitors Z-DEVD.fmk, Z-VAD.fmk and Boc-D.fmk. However, treatment with Z-YVAD.cmk-the gel electrophoresis (data not shown). The concentration dependence of the inhibition of CEM-C7 apoptosis was weakest of the inhibitors in this system-produced only partial inhibition and the 85 kDa cleavage product was similar to that observed for Jurkat cells, except that Z-DEVD.fmk was less potent for CEM-C7s at concentraeasily detected. The effects of the peptide inhibitors on proliferating tions below 50 μM ( Figure 7A Jurkat cells transiently transfected with a pcDNA3-crmA expression construct or the empty vector were allowed to recover for 24 h after electroporation, placed in fresh medium containing anti-Fas antibody (2 ng/ml) for 14 h, and then cloned in soft agar. Colonies were counted after 2 weeks and the number of colony-forming cells per culture was calculated. Means and standard errors from two independent experiments each containing three replicates are shown. Transfection efficiency as determined by staining for β-galactosidase activity was~7%. Z-YVAD.cmk produced a temporary protection of cell viability without apparent proliferation ( Figure 9A ). Z-DEVD.fmk once again produced a striking increase in colony-forming cells protected from apoptosis, Z-VAD. fmk produced a consistent though smaller effect, and Z-YVAD.cmk produced no protection of colony-forming attention has been focused on the possible role of caspases in apoptosis. Loss of functional ced-3 in the nematode abolished developmentally programmed cell death (Ellis in these mice. These studies suggest that, although the mammalian caspase family may together fulfil an essential and Horvitz, 1986) and, if the mammalian Ced-3 homologues, the caspases, were to prove similarly crucial to role in apoptosis analogous to Ced-3 in the nematode, individual caspases are usually not essential for apoptosis, mammalian cell apoptosis, this could undoubtedly have far-reaching medical and biological consequences.
possibly because of redundancy in the biochemical activities of the different family members. It is now clear that the mammalian caspase family has at least 10 members, each with a greater or lesser degree Experimental inhibition of apoptosis by peptide caspase inhibitors or by CrmA therefore has the crucial advantage of sequence homology to Ced-3 (Alnemri et al. 1996; Hale et al., 1996) . However, the production by homologous of inhibiting several caspases at the same time, presenting an opportunity to investigate the importance of this prorecombination of mice genetically deficient in particular caspases has not so far produced the general failure tease family, despite redundancy among its members. The striking protection against commitment to cell death of cell death seen in Ced-3-deficient nematodes. ICE/ caspase-1-deficient mice, for example, are developmentproduced by Z-DEVD.fmk and Z-VAD.fmk in particular strongly confirms the value of this approach. ally normal (Kuida et al., 1995; Li et al., 1995) . Mice deficient in CPP32/caspase-3 live until 1-3 weeks after Since these inhibitors each affect several of the caspases and there are likely to be further members of the family birth but show defective cell death in the brain (Kuida et al., 1996) . However, most cell death-including thymocyte not yet identified, it is thus far impossible to identify unequivocally the enzyme, or enzymes, required for comapoptosis induced by a range of stimuli-occurs normally mitment to cell death in these cells. In addition, we cannot exclude the possibility that differences in inhibition by the peptide inhibitors are related to differences in cell uptake and/or to differences between fluoromethylketone and chloromethylketone inhibitors. Nevertheless, the failure of Z-YVAD.cmk to protect colony-forming ability or proliferation at any concentration in either Jurkat or CEM-C7 cells is consistent with the inability of anti-Fasstimulated Jurkat cell extracts to cleave YVAD (Xiang et al., 1996) . These observations suggest that ICE/ caspase-1 sub-family proteases are not required at this stage. The convincing protection produced by Z-DEVD.fmk in both cell lines, together with the cleavage of DEVD by anti-Fas-stimulated Jurkat cell extracts (Xiang et al., 1996) , indicates that one or more CPP32/caspase-3 sub-family proteases are required for commitment to Fasinduced apoptosis. However, the significant protection produced by CrmA even in a transient expression system, while not excluding involvement of CPP32/caspase-3, does suggest that a different member of the sub-family itself only very poorly (Nicholson et al., 1995) and Fasthe presence of anti-Fas antibody (5 ng/ml) (nigrosin staining) and (B) in a clonogenic assay (as described in the legend to Figure 5 ).
mediated apoptosis occurs normally in thymocytes from
Means and standard errors from two independent experiments each CPP32/caspase-3-deficient mice (Kiuda et al., 1996) . with three replicates are shown.
Although other explanations are possible, we note that the inhibition profile for protection of colony-forming ability, i.e. no protection by Z-YVAD.cmk but protection by include engagement of the T-cell receptor/CD3 complex (Brunner et al., 1995; Dhein et al., 1995; Ju et al., 1995) , Z-DEVD.fmk, by Z-VAD.fmk and by CrmA, is consistent with inhibition of MACH/FLICE/caspase-8 (Boldin et al., the cytotoxic anti-cancer agent doxorubicin (Friesen et al., 1996) and engagement of Class II MHC on activated B 1996; Muzio et al., 1996; F.Li et al., personal communication) . Since this protease is likely to be activated when cells (Truman et al., 1997) . Cells deficient in the caspase activity needed for Fasbound through its death domain to the Fas signalling complex, i.e. at an early stage in the sequence of events induced commitment to apoptosis could therefore be expected to form colonies and, after further genetic induced by Fas engagement, it is reasonable to suggest that MACH/FLICE/caspase-8 activity may indeed be changes, either form cancers or, for cells carrying autoreactive T-cell receptors, produce auto-immune disease. required for commitment to apoptosis in this system.
Whatever the precise identity of the protease or proteases Apoptosis in Rat-1 fibroblasts is not completely inhibited by inhibition of caspases (McCarthy et al., involved, these observations have several important consequences for our understanding of apoptosis and disease. 1997). This suggests that mammalian cell apoptosis is heterogeneous in this respect and the exact role of the They indicate that genetic abolition of the relevant caspases could lead to inappropriate survival of cells signalled to die proteases must be determined for different biological systems. In addition, even in Jurkat, one of the cell lines through Fas. Apoptosis induced through Fas is important in several areas of the immune system (Rouvier et al., 1993;  used in the present study, cell death induced by a different stimulus, Bax over-expression, is not blocked by Nagata and Golstein, 1995) and recent work has shown that Fas normally acts as a tumour suppressor for B-cell Z-VAD.fmk or Boc-D.fmk (Xiang et al., 1996) , indicating that a requirement for caspase activity for commitment to lymphoma (Peng et al., 1996) . In addition, several groups have reported that other inducers of apoptosis act through cell death can differ for stimuli within the same cell. Nevertheless, we suggest that commitment to apoptosis stimulation of Fas/Fas-ligand interaction. These stimuli in other systems will also prove to be dependent on these temperature with a total of 40 μg DNA at 310 V, 960 μF in 0.4 cm proteases, offering the prospect of genuine rescue from cuvettes (Bio-Rad). In order to follow transfection efficiency, pcDNA3-apoptosis by specific protease inhibitors as a novel crmA or the empty vector were co-transfected with the pSV β-Gal approach to therapy of degenerative disease. plasmid (Promega) at a ratio of 1:1. At 24 h post-transfection, half the cells were stained for β-galactosidase activity (MacGregor, 1992) . The remaining cells were treated with 2 ng/ml anti-Fas for 14 h. Clonogenic
Materials and methods
survival was determined by cloning in soft agar as described above.
Materials
The protease inhibitors benzyloxycarbonyl-Val-Ala-Asp(OMe)fluoro- Nagata,S. (1996) Sequential fragmentation was examined as described previously (Smith et al., 1989 Kuida,K., Zheng,T.S., Na,S., Kuan,C., Yang,D., Karasuyama,H., Rakic,P. the mammalian expression vector pcDNA3 (Invitrogen). The resulting and Flavell,R.A. (1996) Decreased apoptosis in the brain and premature expression construct, or pcDNA3 itself as a control, was introduced into Jurkat cells by electroporation (Gene Pulser, Bio-Rad). 8ϫ10 6 cells in lethality in CPP32-deficient mice. Nature, 384, 368-372.
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